Pemphigus Unknown Status Phase 3 Trials for Rituximab (DB00073)

IndicationStatusPhase
DBCOND0001806 (Pemphigus)Unknown Status3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01974518Comparative Study of Rituximab Versus Combination of Rituximab and Intravenous Cyclophosphamide in Severe PemphigusTreatment